In the present study we report the occurrence of -aspartic acid (-Asp) in the ovary of the green frog Rana esculenta and its putative involvement in testosterone production by the gonad. In the ovary, -Asp concentrations undergo significant variations during the main phases of the sexual cycle. In spawning females (March), its concentration was low (2·5 1·1 nmol/g ovary) and during the postreproductive period ( June) it increased and reached its peak level (58·0 10·1 nmol/g) in October. In that month, vitellogenesis occurs in a new set of ovarian follicles and continues until the next spring. The concentrations of -Asp in the ovary and of testosterone in the ovary and in the plasma were inversely correlated during the reproductive cycle: when endogenous -Asp was low (March), testosterone was high (36·9 4·8 ng/g ovary; 23·1 2·76 ng/ml plasma) and, in contrast, when the -Asp concentration was high (October), the testosterone concentration was low (0·86 0·21 ng/g ovary and 5·0 1·3 ng/ml plasma). In vivo experiments, consisting of injection of -Asp (2·0 µmol/g body weight) into the dorsal lymphatic sac of adult female frogs, demonstrated that this amino acid accumulates significantly in the ovary. After 3 h, moreover, it caused a decrease in testosterone level in the plasma of about 80%. This inhibition was reversible: within 18 h after the amino acid injection, as the -Asp concentration in the ovary decreased, the testosterone titre was restored in both ovary and plasma.
Introduction
-Aspartic acid (-Asp) is an endogenous amino acid occurring as a free acid in several species of vertebrates and invertebrates, although it is present in very low concentrations compared with -Asp. It is not metabolized by the common enzymatic systems involved in the catalysis of -amino acids, but is recognized by receptors for N-methyl--aspartic acid (NMDA) such as -Asp and -glutamic acid (-Glu) (Davies & Johnston 1976 , Skerritt & Johnston 1981 , Simpson et al. 1988 ). -Asp has been found in the nervous tissue of cephalopods, Octopus vulgaris, Loligo vulgaris and Sepia officinalis (D'Aniello & Giuditta 1977 , 1978 , D'Aniello et al. 1995b , the opisthobranch mollusc, Aplysia fasciata (D'Aniello et al. 1992a) , and the tunicate, Ciona intestinalis (D'Aniello et al. 1992b ). Among vertebrates, free -Asp has been found in the nervous tissue of chickens (Neidle & Dunlop 1990) , rodents (Dunlop et al. 1986 , D'Aniello et al. 1993a , Hashimoto et al. 1993b ) and humans (Fisher et al. 1991 , 1994 , Hashimoto et al. 1993a . More recently, studies have shown that this enantiomer is also present in other body structures, including the endocrine glands and reproductive organs of the rat (Hashimoto et al. 1993b , D'Aniello et al. 1996 and in the sexual glands of Octopus vulgaris (D'Aniello et al. 1995a) . These findings suggested a novel role for -Asp as a regulator of reproductive activity. -Asp, indeed, may intervene in the control of sex hormone synthesis -an assumption supported by the observation that, in adult male rats, -Asp induces a significant increase in circulating luteinizing hormone (LH) and testosterone (D'Aniello et al. 1996) . Moreover, in the rat testis, -Asp accumulates in Leydig and Sertoli cells and in vivo experiments conducted on isolated testes demonstrated that this amino acid enhances the production of testosterone (D'Aniello et al. 1996) . These data indicate that -Asp may act as a local putative regulator of androgen production.
It is not known whether the -Asp influence on gonadal testosterone synthesis is indigenous only to rodent species or is a common feature among vertebrates. To obtain an answer to this question we carried out a similar study on a different class of vertebrate, to discover if such phenomena occur in an amphibian species, the green frog, Rana esculenta. This frog was chosen because of a peculiar characteristic of its reproductive endocrinology: in the female, during the sexual cycle, besides specific modifications in plasma progesterone and 17 -oestradiol concentrations, a sustained titre of circulating testosterone occurs, which is greater than that found in the male (Paolucci et al. 1990) . Like most amphibians living in temperate zones, Rana esculenta is a typical seasonal breeder (Lofts 1984) . Mating and egg deposition occur in spring, when most females lay about 1000 eggs. After a few weeks of gonadal quiescence in summer (post-reproductive period), vitellogenesis slowly resumes and, starting in late October, a set of new follicles progressively grows to become ripe at the end of the next winter (recovery period) (Rastogi et al. 1983 , Lofts 1984 . In the female, increased concentrations of plasma testosterone are observed during the recovery period and in the early phase of the reproductive period (Rastogi et al. 1983 , Paolucci et al. 1990 ).
Materials and methods

Animals
Adult female green frogs, Rana esculenta, were collected from ponds on the outskirts of Naples during relevant phases of their reproductive cycle, namely the beginning of the breeding season (March), the post-reproductive period ( June) and the early phase of the recovery period (October).
Soon after capture, the frogs were anaesthetized by brief immersion in a 1% solution of ethyl aminobenzoate in water and the plasma was collected through a heparinized glass capillary inserted into the heart. The blood was centrifuged at 3000 g for 15 min and the plasma was stored at 80 C until required for analysis. The animals were then dissected and visually inspected to ascertain the stage of ovarian development. The frogs' ovaries, the development of which was consistent with the presumed period of the sexual cycle, were removed and weighed. Thereafter, pituitary and adrenal glands were excised. It should be noted that, in this amphibian, adrenal gland and kidney are partially intermingled and consequently it is not easy to obtain pure adrenal tissue. Therefore, after removal of the adrenal, a small sample was subjected to histological examination. Those samples that were contaminated by kidney remnants were discarded. All tissues were rapidly used or stored at 80 C.
For experimental studies, groups of frogs captured in different phases of the sexual cycle were reared in a laboratory aquarium, kept at ambient photothermal regimes: 11 h light : 13 h darkness, 10 C in March; 16 h light : 8 h darkness, 24 C in June and 11 h light : 13 h darkness, 18 C in October. The frogs were fed meal worms that were available ad libitum. After 1 week they were studied as reported below.
In vivo experiments
The in vivo experiments consisted of injecting into the dorsal lymphatic sac of adult females, an appropriate volume of 0·5 M amino acid in the or form (Sigma, Milan, Italy), dissolved in amphibian saline solution (pH 7·4), to obtain 2·0 µmol amino acid/g body weight. This dose was used for each amino acid tested because, in preliminary experiments in which the frogs were injected with different amounts of -Asp (0·5-5·0 µmol/g body weight), it was the lowest dose that produced statistically significant effects. Control frogs received the appropriate amount of physiological amphibian saline. Usually, the number of frogs included in every in vivo experiment was managed in order to obtain at least five specimens for each test point. At different times after drug administration (from 0 to 18 h), frogs were killed and blood and ovaries were collected. In these in vivo experiments, samples of whole ovary, rather than isolated follicles, were used for the determination of -Asp uptake (see below).
In vitro experiments
For in vitro experiments, ovaries were dissected and the vitellogenetic follicles were carefully separated under a light microscope by means of small scissors. The rest of the ovary was discarded. Isolated follicles, including their oocyte, were gently mixed with 200 ml Krebs-Ringer nutrient medium (NaCl 0·11 M, KCl 0·046 M, CaCl 2 0·019 M, MgCl 2 0·066 M, NaHCO 3 0·025 M, NaH 2 PO 4 0·014 M), supplemented with: glucose 0·015 M, BSA 2 mg/ml, metabolites (NAD, NADH, flavine mononucleotide, ATP, AMP, pyridoxal phosphate, thymidine, cytidine, guanine and ribose, 0·1 mg/ml each), ions (iron, calcium, magnesium and zinc, 0·1 mM each) and antibiotics (penicillin (50 IU/l), streptomycin (50 IU/l), neomycin (50 IU/l) and nistatin (100 IU/l)). This mixture was filtered through a cell dissociation sieve (50 mesh screens, Sigma). Unbroken follicles remaining on the filter were washed again with the Krebs-Ringer nutrient medium and collected; broken follicles were discarded. Depending on the stage of the sexual cycle, follicles from a pool of two to six ovaries were used for each experiment. Collected follicles were distributed (1 g each) into multi-well plates (six wells) then 3 ml Krebs-Ringer medium were added to each well and mixed with 12 µl 0·5 M sodium -aspartate at pH 7·4 (2·0 µmol/ml medium) or with 12 µl saline (controls). These suspensions were incubated at 37 C for 3 h, using a shaking bath. At the end of the incubations, the mixtures were left to settle for 4-5 min and the tissues and the supernatants were separated and used for testosterone determination, as reported below. The 3-h incubation time utilized in our tests was chosen on the basis of in vivo effects of -Asp on plasma testosterone concentrations and on the pattern of uptake of -Asp by the ovary (see below). As no significant differences in the pattern of effects of -Asp on testosterone were observed using incubation temperatures in the range 20-40 C, an incubation temperature of 37 C was chosen for practical reasons and, therefore, used routinely in all subsequent in vitro experiments.
In a typical experiment, two wells were run, containing follicles plus -Asp and follicles plus amphibian saline respectively. For each period, these tests were repeated five times using follicle pools from different animals. On parallel incubations of follicles from females collected in March, the effect of a homologous pituitary, in the presence or absence of -Asp, was also studied. Two additional incubations were therefore carried out, containing follicles plus -Asp plus one homologous whole pituitary, and follicles plus amphibian saline plus one homologous whole pituitary respectively. The same kind of experiments were run with adrenal tissue. In each well, 0·2 g of adrenal tissue were added, in the presence or absence of -Asp; however, pituitary tissue was never used.
Testosterone assay
Testosterone contents were determined by radioimmunoassay as described by d' Istria et al. (1974) . The limit of detection was 3 pg per assay tube (intra-assay variation 5·7%, interassay variation 12%).
Plasma samples or incubation medium, obtained from in vivo and in vitro experiments, were mixed with ethyl ether in a ratio of 1 : 10, mixed for 5 min and centrifuged at 3000 g for 10 min. The upper phase (ethyl ether) was transferred to a glass tube (16 100 mm) and the extraction was repeated twice. Pooled ether phases were left to evaporate on a hot-plate at 40-50 C under a hood. The residue was dissolved in 0·5 ml sodium phosphate buffer 0·05 M, pH 7·5, containing BSA at a concentration of 20 mg/ml (this served to bind the testosterone to albumin and adapt it for assay), and 0·1 ml of this last mixture was used for the assay.
Tissues (ovarian follicles or adrenal glands) were homogenized 1 : 5 (w/v) with distilled water. The homogenate was then mixed vigorously with ethyl ether (1 : 10) and the ether phase was withdrawn after centrifugation at 3000 g for 10 min. The extraction was repeated twice.
Pooled ether extracts were dried and finally treated as described above.
Preparation of samples for amino acid analysis
Ovarian samples were homogenized with 0·5 M perchloric acid (PCA) in a ratio of 1 : 10. They were then centrifuged at 30 000 g for 20 min. The supernatants were neutralized with 5 M KOH to pH 7·5-8·5. The samples were then cooled for 30 min at 0 C to allow the maximum precipitation of potassium perchlorate (formed by the reaction between PCA and KOH) and then they were centrifuged as above. The supernatants were brought to a pH of about 2·5 with 1 M HCl, and the amino acids were purified on a cation exchange column (1 3 cm) (AG 50W-X8 resin, hydrogen ionic form, 200-400 mesh obtained from Bio-Rad laboratories), previously regenerated by washing the resin with an excess of 2 M NaOH, then with distilled water, then with an excess of 4 M HCl, and finally equilibrated with 0·01 M HCl. After absorption of the samples, the columns were washed with 10 ml 0·01 M HCl. Finally, the amino acids were eluted with 8 ml 4 M NH 4 OH. These eluates were evaporated (in small Petri dishes) on a hot-plate at 40-60 C, under a hood. The residues were dissolved in 1 ml HCl 0·01 M and further purified on a Sep-pak cartridge C-18 (300 mg; Waters, Milan, Italy) as follows. The samples were passed slowly through the cartridges (previously activated with methanol or acetonitrile and then washed with distilled water) with a syringe, and then the cartridges were eluted twice with 2 ml 0·1 M HCl, pH 8·2, to recover all the amino acids. Both eluates were combined and dried using a Savant centrifuge, or left to evaporate in small Petri dishes at 40-50 C under the hood. Finally, the residues were dissolved in 200 µl 0·01 M HCl and analysed for the presence of -amino acids.
Enzymatic colorimetric method for the determination of -aspartic acid, -glutamic acid and NMDA Concentrations of these three -amino acids were determined using a specific enzymatic colorimetric assay based on the use of -aspartate oxidase (EC 1.4.3.3.) as described by D' Aniello & Giuditta (1977) . Slight modifications were as follows: 50 µl purified samples were mixed with 10 µl Tris-HCl 1 M pH 8·2 and with 2 µl -aspartate oxidase (5 mg/ml). The mixtures were incubated at 37 C for 30 min and then mixed with 10 µl 2,4 dinitrophenylhydrazine (5 mM) in HCl (5 M). After 20 min at room temperature, 400 µl NaOH (0·5 M) were added. The mixture was mixed and after 10 min the absorbance was read at 445 nm. The blank consisted of the same assay mixture, but without -aspartate oxidase. As a standard, 10 µl of a solution of 1 mM -aspartate and 40 µl distilled water was used instead of a sample. Using this method, it is possible to determine only the sum of -Asp, -Glu and D-Aspartic acid and control of testosterone production · M M DI FIORE and others 201
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Enzymatic u.v. method for the determination of -aspartic acid plus NMDA These two amino acids were assayed specifically by oxidation with -aspartate oxidase (-AspO) and measurements of the oxaloacetate were made by means of a coupling reaction with NADH and malate dehydrogenase (MDH) according to the method of D'Aniello and Giuditta (1977) , which was based on the following principle:
The decrease in NADH was measured by the change in optical density at 340 nm. In brief, 0-400 µl sample to be analysed (previously brought to pH 7·5-8·5) were put in an Eppendorf tube and mixed with distilled water to a final volume of 400 µl. After that, 40 µl 2 M Tris-HCl (2 M) pH 8·2, 40 µl NADH (Boehringer, solution 2 µmol/ml, in Tris-HCl 0·2 M, pH 8·2) and 2 µl MDH (5000 IU/ml, Boehringer) were added and the assay mixture was mixed and incubated at 37 C for 10 min (this served to eliminate endogenous oxaloacetate present in the sample). After the incubation, the sample was centrifuged at 30 000 g for 5 min. The supernatant was transferred to a microcuvette and the absorbance was read at 340 nm against distilled water. Thereafter, 2 µl -aspartate oxidase (5 mg/ml, purified from the hepatopancreas of Octopus vulgaris; D'Aniello & Giuditta 1977) were added to the assay mixture, mixed and incubated for 10 min at 37 C. After incubation, the tube was centrifuged as above and the supernatant was read again at 340 nm. For a blank sample the same procedure was used, except that -aspartate oxidase was not added.
For a standard the same procedure was used, except that 100 µl -Asp standard in a concentration of 1 µmol/ml and distilled water to a volume of 400 µl was used instead of sample.
Specific HPLC method for the determination of -aspartic acid
This amino acid was specifically determined using an HPLC chromatographic method described by Aswad (1984) and slightly modified as follows: 5-20 µl each sample were mixed with 20 µl 0·1 M NaOH (to obtain a final pH of about 9·5) and 10 µl o-phthaldialdehyde-Nacetyl--cysteine (OPA-NAC) reagent, prepared as follows: 4 mg OPA were dissolved in 300 µl methanol and then mixed with 500 µl 0·5 M borate buffer, pH 9·5, and 60 µl 1 M solution of NAC (previously brought to pH 5-6 with 4 M NaOH). After 2 min, 0·1 M sodium borate buffer, pH 9·5, was added to a final volume of 400 µl. Twenty microlitres of this mixture were injected onto a Supercosil C-18 HPLC column (0·45 25 cm; 5 µm beads; Supelco, Bellefonte, PA, USA) and the amino acids were eluted using a two-pump system. Buffer A consisted of 28 ml 1 M sodium acetate buffer, pH 5·5 (final 30 mM), 950 ml double-distilled water and 20 ml acetonitrile (2%). Buffer B consisted of 9·0 ml 1 M acetate buffer, pH 5·5 (final concentration 30 mM), 291 ml double-distilled water and 700 ml acetonitrile (70%). A linear gradient was developed from 0% B to 20% B over 20 min and then 100% B in 5 min. The flow rate was maintained at 1·2 ml/min throughout. The amino acid derivatives were detected fluorimetrically using excitation at 330 nm and emission at 450 nm. The standard curve consisted of 20 µl of a mixture containing 17 different -amino acids (in 0·1 M HCl), including -Asp, each in a concentration of 0·1 µmol/ml, 10 µl -Asp in a concentration of 0·02 µmol/ml, 20 µl 0·1 M NaOH and 10 µl OPA-NAC reagent. After 2 min, 0·1 M sodium borate buffer, pH 9·5, was added to a final volume of 400 µl. In this case also, 20 µl were injected as above.
Determination of -glutamic acid
The amount of -glutamic acid was calculated as the difference between the total amount of -Asp, NMDA and -Glu determined by the enzymatic colorimetric method minus the sum of -Asp and NMDA obtained by the enzymatic u.v. method.
Determination of -alanine -Alanine was assayed enzymatically according to the method reported above, except that hog kidney -amino acid oxidase (Boehringer, Mannheim) was used instead of -aspartate oxidase (D'Aniello et al. 1993b ).
Statistical analysis
Data were analysed by one-way ANOVA followed by Duncan's multiple-range test. In addition, the correlation coefficient (r) between -Asp content in the ovary and the plasma testosterone concentration was calculated. Figure 1 shows the endogenous concentration of -aspartic acid in the ovary and the concentration of testosterone both in the plasma and in the gonad, in female Rana esculenta, collected during the major phases of the sexual cycle. The -Asp content in the ovary increased progressively from the breeding season to the early recovery period (reproductive and post-reproductive periods compared, P<0·05; post-reproductive and early recovery periods compared, P<0·01), whereas testosterone concentrations in the ovary and plasma progressively decreased (ovary: reproductive and post-reproductive periods compared, P<0·01; post-reproductive and early recovery periods compared, P<0·05; plasma: reproductive and post-reproductive periods compared, P<0·05; postreproductive and early recovery periods compared, not significant). Comparison of ovarian -Asp content with testosterone concentrations in the ovary and the plasma revealed a reverse correlation between the amino acid and the hormone throughout the sexual cycle (-Asp and ovarian testosterone concentration compared, r= 0·773, P<0·01; -Asp and plasma testosterone concentration compared, r= 0·751, P<0·01). In March, the concentration of -Asp in the ovary is very low (2·5 1·1 nmol/ g) compared with that in June (20·0 3·1 nmol/g) and that in October, when the maximum concentration occurs (58·0 10·1 nmol/g). In contrast, the ovarian and plasma concentrations of testosterone are greater in March (36·9 4·8 ng/g and 23·1 2·76 ng/ml respectively) than in either June or October. In June, both -Asp and testosterone are at concentrations between those observed in March and October (Fig. 1) .
Results
In the in vivo experiments, in which adult females were injected with -Asp (2·0 µmol/g body weight), the administration of this enantiomer to frogs collected in March was followed by a significant decrease in circulating testosterone (Fig. 2) . Three hours after treatment, the plasma testosterone concentration decreased from 23·0 2·76 ng/ml as measured in control animals to 4·1 0·5 ng/ml found in treated animals (P<0·01). However, this effect appeared to be reversible, because the plasma testosterone concentration was almost restored within 18 h after the treatments (3 h compared with 6 h, P<0·01; 6 h compared with 18 h, P<0·05). This -Aspdependent effect was less evident in frogs captured in June (not shown) and absent in those obtained in October (Fig. 2) .
-Asp, injected in vivo to female frogs collected in October, was accumulated by the ovary to a greater extent than were other amino acids (-Ala and -Glu). As shown in Fig. 3 , -Asp was rapidly taken up by the gonad so that, 1 h after injection, its concentration in the ovary was about 10 times greater than the values observed in females injected with saline. It then progressively decreased and reached baseline values within 18 h (Fig. 3) . It should be noted that the concentration of -Asp in the ovarian tissue remained increased 3 h after injection. -Ala also was accumulated by the ovary, but its uptake was much lower than that of -Asp; the uptake of -Glu was minimal. Figure 4 shows the effects of treatment with three different or -amino acids (-and -Asp, and -Ala, and -Glu) on the plasma concentration of testosterone in female frogs captured in March. It can be seen that, 6 h after the amino acid injection, the plasma concentration of testosterone had decreased only in -Asp-treated females (P<0·01); no significant effects were observed with the other amino acids studied. Table 1 summarizes the results of in vitro experiments. After 3 h of incubation at 37 C in wells containing ovarian follicles from females collected in March, a significantly lower testosterone concentration was observed both in tissues and in medium when -Asp (2·0 µmol/ml medium) was added to the medium (P<0·01). Similar effects were also observed when experiments were performed in the presence of pituitary tissue (P<0·01). These results were less evident when June follicles were used and absent with October follicles (not shown). In the incubations with follicles from females collected in March, in which one homologous whole pituitary was added in the presence or absence of -Asp, an increase in testosterone was registered in follicles and medium (control follicles and follicles plus pituitary tissue compared, P<0·05; -Asp-treated follicles and follicles plus -Asp plus pituitary tissue compared, P<0·05; medium of control follicles and medium of control follicles plus pituitary tissue compared, not significant; medium of -Asp-treated follicles and medium of -Asp-treated follicles plus pituitary tissue compared, P<0·05). It should be noted that the increase in testosterone was similar in wells containing -Asp or devoid of this enantiomer. Finally, the addition of -Asp to wells containing adrenal tissue did not influence the testosterone concentration in either adrenal tissue or medium (Table 1) .
Discussion
To our knowledge, this is the first report on the presence of -Asp in the ovarian tissue of a lower vertebrate. We have found that, in female Rana esculenta, -Asp is contained in the ovary and its concentration undergoes modifications throughout the sexual cycle. In the ovary, the amino acid is present in very low concentrations in frogs entering the breeding season (March), then increases during the post-reproductive period and reaches a relatively high concentration in the early recovery period (October), when a new set of ovarian follicles starts vitellogenesis to become ripe in the next spring. Moreover, in vivo, the ovary takes up -Asp in significantly greater amounts than it does other -amino acids (-Ala and -Glu). The presence of -Asp in the frog ovary is consistent with previously published data on its occurrence in animal gonads (Hashimoto et al. 1993b , D'Aniello et al. 1995a , 1996 . The source of -Asp in animal tissues has not yet been defined. Tentatively it could be proposed that the amino acid comes either from an exogenous sourcethe insects and worms (Corrigan 1969 ) that constitute the diet of frogs -or by in loco conversion of -forms by a specific racemase. Further study is needed to address this point in female Rana esculenta.
Comparison of the ovarian -Asp content with testosterone concentrations in the gonad and in the plasma indicates a reverse correlation between -Asp and testosterone titres. In females collected in March, the testosterone concentration was high in ovary and plasma and coincided with the very low concentrations of -Asp in the ovary. Conversely, in October, the testosterone concentration was low in ovary and plasma and coincided with high amounts of -Asp in the ovary. In June, decreasing titres of testosterone were coupled to increasing amounts of this amino acid.
The -Asp profile in the ovary during the sexual cycle and its correlation with testosterone concentrations in the ovary and in the plasma support previous hypotheses implicating this amino acid in the control of the production of testosterone by the gonad (D'Aniello et al. 1995a (D'Aniello et al. , 1996 . In Rana esculenta females, this assumption is sustained by the results of in vivo and in vitro experiments. In fact, the administration of -Asp to adult females, obtained at the beginning of the breeding period when the plasma testosterone is high (March), induces a significant decrease in the plasma testosterone concentration, which reaches its lowest value in treated females 3 h after injection of the amino acid. In vitro addition of -Asp to ovarian follicles from reproductive females induced a significant decrease in the testosterone concentration both in tissues and in the incubation medium. These results differ from those reported by D' Aniello et al. (1996) in male rats, in which -Asp appears to induce an increase rather than an inhibition of testosterone production by the gonad. These differences could be sex-dependent, although, in our previous unpublished studies, -Asp failed to induce any consistent alteration in the plasma concentration of testosterone in male frogs. The differences between the effects of -Asp in these two vertebrates remain, at present, unexplained.
The effect of -Asp on ovarian and plasma testosterone is reversible, as the decrease in testosterone in ovary and plasma of -Asp-treated females occurred within the first 3-6 h after injection of the amino acid; thereafter, the hormone concentration was progressively restored. The pattern of -Asp uptake by the ovary can help to explain this aspect. When injected into female frogs, -Asp rapidly accumulated in the ovary, but its concentration decreased progressively to basal values within 18 h. Therefore, in females treated with -Asp, the plasma testosterone decrease occurs as long as sustained concentrations of -Asp are present in the gonad. This agrees with the observation in freshly captured animals that a greater -Asp content in the gonad coincides with a lower testosterone content both in the gonad and in the plasma, and vice versa.
The inhibitory effect of -Asp appears to be specific, as other and -amino acids (-Asp, and -Ala, and -Glu), tested under the same conditions, did not accumulate in the gonad and did not cause significant inhibition of testosterone release.
In the male rat, the action of -Asp on the release of testosterone appears to be both indirect (through an increase in LH release) and direct (on the testis endocrine components). At present, our in vitro experiments in the green frog support only a direct effect of -Asp on the ovarian follicles. In fact, the addition of one homologous whole pituitary to the incubation medium containing follicles of reproductive female ovary induced the same rate of testosterone increase, independently of the presence or absence of -Asp in the medium.
The results of in vitro experiments suggest the ovarian follicles as the putative target of -Asp action and, moreover, indicate that -Asp inhibitory effects occur only if Table 1 In vitro effects of D-Asp on the tissue content of testosterone and release of testosterone from ovarian follicles and adrenal gland samples of the female green frog, Rana esculenta. Follicles were from frog ovaries obtained during the breeding season (March). Incubations were carried out for 3 h at 37 C. Each value is the mean S.D. of five different determinations, each from a pool of two to six ovaries Control follicles compared with follicles plus pituitary tissue, P<0·05; D-Asp-treated follicles compared with follicles plus D-Asp plus pituitary tissue, P<0·05; medium of control follicles compared with medium of control follicles plus pituitary tissue, not significant; medium of D-Asp-treated follicles compared with medium of D-Asp-treated follicles plus pituitary tissue, P<0·05. D-Aspartic acid and control of testosterone production · M M DI FIORE and others 205
Journal of Endocrinology (1998) 157, 199-207 ovarian follicles of reproductive frogs (March) are used. -Asp was less efficacious when applied to follicles of females captured in June, and failed to induce any testosterone decrease in follicles of animals caught in October. It could be supposed that this depends on the endogenous content of -Asp in the follicles: as its concentration increases in June and October follicles, the amino acid slows down the normal testosterone production. This could render any additional exogenous -Asp ineffective. The cellular target for -Asp in the frog follicles remains to be identified, although it may be the endocrine cells of the follicle wall, in which the production of androgen has also been widely explored in frog ovary (Fortune 1983 , Lofts 1984 , Kime 1987 , Gore-Langton & Armstrong 1988 . The mechanism of action of -Asp on the gonad target cells, however, requires more investigation, as the decrease in testosterone production could be due either to an inhibition of hormone synthesis or to an increase in testosterone metabolism. At present, no data are available to settle the question. Finally, the effect of -Asp on the ovary seems to be organ-specific because, at least in vitro, this amino acid failed to induce any modification in the testosterone concentration in adrenal gland, although effects on other adrenal steroids, not determined in this study, cannot be ruled out.
In conclusion, our data confirm a putative role of -Asp in the regulation of androgen production by the gonad, and indicate that this effect appears not to be limited to mammals. However, the different effects of -Asp on testosterone concentrations in the rat and in the green frog, Rana esculenta, lead us to suppose that -Asp can assume different roles, excitatory or inhibitory, depending on species and sex.
